ALIF B Stock Overview
Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
AddLife AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 149.60 |
| 52 Week High | SEK 169.80 |
| 52 Week Low | SEK 94.65 |
| Beta | 1.34 |
| 1 Month Change | 8.96% |
| 3 Month Change | 10.49% |
| 1 Year Change | 32.74% |
| 3 Year Change | -45.56% |
| 5 Year Change | 98.80% |
| Change since IPO | 444.00% |
Recent News & Updates
AddLife (STO:ALIF B) Seems To Use Debt Quite Sensibly
Jan 08
There Is A Reason AddLife AB (publ)'s (STO:ALIF B) Price Is Undemanding
Dec 05Recent updates
AddLife (STO:ALIF B) Seems To Use Debt Quite Sensibly
Jan 08There Is A Reason AddLife AB (publ)'s (STO:ALIF B) Price Is Undemanding
Dec 05Does AddLife (STO:ALIF B) Have A Healthy Balance Sheet?
Oct 02AddLife AB (publ) (STO:ALIF B) Surges 26% Yet Its Low P/S Is No Reason For Excitement
Jul 26AddLife's (STO:ALIF B) Weak Earnings May Only Reveal A Part Of The Whole Picture
Jul 22Earnings Update: Here's Why Analysts Just Lifted Their AddLife AB (publ) (STO:ALIF B) Price Target To kr155
Jul 18Revenues Working Against AddLife AB (publ)'s (STO:ALIF B) Share Price
May 29Are Investors Undervaluing AddLife AB (publ) (STO:ALIF B) By 42%?
Apr 22Is It Time To Consider Buying AddLife AB (publ) (STO:ALIF B)?
Apr 06AddLife AB (publ) Just Missed Earnings - But Analysts Have Updated Their Models
Feb 07AddLife AB (publ)'s (STO:ALIF B) 28% Share Price Surge Not Quite Adding Up
Dec 19AddLife (STO:ALIF B) Has A Somewhat Strained Balance Sheet
Dec 09Is It Too Late To Consider Buying AddLife AB (publ) (STO:ALIF B)?
Nov 21Is There An Opportunity With AddLife AB (publ)'s (STO:ALIF B) 43% Undervaluation?
Oct 14AddLife (STO:ALIF B) Has A Somewhat Strained Balance Sheet
Sep 08Is Now The Time To Look At Buying AddLife AB (publ) (STO:ALIF B)?
Aug 18Calculating The Fair Value Of AddLife AB (publ) (STO:ALIF B)
Jul 05Is Now An Opportune Moment To Examine AddLife AB (publ) (STO:ALIF B)?
May 18Is AddLife (STO:ALIF B) Using Too Much Debt?
Apr 28AddLife (STO:ALIF B) Is Paying Out Less In Dividends Than Last Year
Apr 05AddLife (STO:ALIF B) Is Paying Out Less In Dividends Than Last Year
Feb 21AddLife (STO:ALIF B) Has Announced That Its Dividend Will Be Reduced To SEK1.20
Feb 07Should You Think About Buying AddLife AB (publ) (STO:ALIF B) Now?
Jan 20AddLife (STO:ALIF B) Has A Pretty Healthy Balance Sheet
Dec 30Calculating The Fair Value Of AddLife AB (publ) (STO:ALIF B)
Oct 27Should You Think About Buying AddLife AB (publ) (STO:ALIF B) Now?
Oct 11Is AddLife (STO:ALIF B) A Risky Investment?
Sep 23When Should You Buy AddLife AB (publ) (STO:ALIF B)?
Jul 11Shareholder Returns
| ALIF B | SE Life Sciences | SE Market | |
|---|---|---|---|
| 7D | 3.5% | 1.1% | 1.1% |
| 1Y | 32.7% | -0.3% | 13.3% |
Return vs Industry: ALIF B exceeded the Swedish Life Sciences industry which returned 0.7% over the past year.
Return vs Market: ALIF B exceeded the Swedish Market which returned 12.5% over the past year.
Price Volatility
| ALIF B volatility | |
|---|---|
| ALIF B Average Weekly Movement | 4.5% |
| Life Sciences Industry Average Movement | 9.1% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.7% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: ALIF B has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: ALIF B's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1906 | 2,356 | Fredrik Dalborg | www.add.life |
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments.
AddLife AB (publ) Fundamentals Summary
| ALIF B fundamental statistics | |
|---|---|
| Market cap | SEK 18.23b |
| Earnings (TTM) | SEK 117.00m |
| Revenue (TTM) | SEK 10.01b |
155.8x
P/E Ratio1.8x
P/S RatioIs ALIF B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALIF B income statement (TTM) | |
|---|---|
| Revenue | SEK 10.01b |
| Cost of Revenue | SEK 6.28b |
| Gross Profit | SEK 3.74b |
| Other Expenses | SEK 3.62b |
| Earnings | SEK 117.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 05, 2025
| Earnings per share (EPS) | 0.96 |
| Gross Margin | 37.31% |
| Net Profit Margin | 1.17% |
| Debt/Equity Ratio | 95.9% |
How did ALIF B perform over the long term?
See historical performance and comparisonDividends
0.3%
Current Dividend Yield52%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/29 09:53 |
| End of Day Share Price | 2025/01/29 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
AddLife AB (publ) is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Karl Norén | Danske Bank |
| Gustav Berneblad | Nordea Markets |